These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11751145)

  • 1. In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.
    Arikan S; Lozano-Chiu M; Paetznick V; Rex JH
    Antimicrob Agents Chemother; 2002 Jan; 46(1):245-7. PubMed ID: 11751145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp.
    Philip A; Odabasi Z; Rodriguez J; Paetznick VL; Chen E; Rex JH; Ostrosky-Zeichner L
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3572-4. PubMed ID: 16048988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro synergy of caspofungin and itraconazole against Aspergillus spp.: MIC versus minimal effective concentration end points.
    Shalit I; Shadkchan Y; Samra Z; Osherov N
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1416-8. PubMed ID: 12654681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal interactions within the triple combination of amphotericin B, caspofungin and voriconazole against Aspergillus species.
    O'Shaughnessy EM; Meletiadis J; Stergiopoulou T; Demchok JP; Walsh TJ
    J Antimicrob Chemother; 2006 Dec; 58(6):1168-76. PubMed ID: 17071635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of caspofungin combined with sulfamethoxazole against clinical isolates of Aspergillus spp.
    Yekutiel A; Shalit I; Shadkchan Y; Osherov N
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3279-83. PubMed ID: 15328085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of disk diffusion with microdilution assay in susceptibility testing of caspofungin against Aspergillus and Fusarium isolates.
    Arikan S; Paetznick V; Rex JH
    Antimicrob Agents Chemother; 2002 Sep; 46(9):3084-7. PubMed ID: 12183278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against aspergillus spp.
    Serrano Mdel C; Valverde-Conde A; Chávez M M; Bernal S; Claro RM; Pemán J; Ramirez M; Martín-Mazuelos E
    Diagn Microbiol Infect Dis; 2003 Feb; 45(2):131-5. PubMed ID: 12614985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates.
    Arikan S; Lozano-Chiu M; Paetznick V; Rex JH
    Antimicrob Agents Chemother; 2001 Jan; 45(1):327-30. PubMed ID: 11120990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of the echinocandin caspofungin with amphotericin B or voriconazole against Aspergillus biofilms in vitro.
    Liu W; Li L; Sun Y; Chen W; Wan Z; Li R; Liu W
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6414-6. PubMed ID: 23027186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of fluorescent probes to determine MICs of amphotericin B and caspofungin against Candida spp. and Aspergillus spp.
    Peter J; Armstrong D; Lyman CA; Walsh TJ
    J Clin Microbiol; 2005 Aug; 43(8):3788-92. PubMed ID: 16081911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp.
    Perea S; Gonzalez G; Fothergill AW; Kirkpatrick WR; Rinaldi MG; Patterson TF
    Antimicrob Agents Chemother; 2002 Sep; 46(9):3039-41. PubMed ID: 12183266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi.
    Pfaller MA; Marco F; Messer SA; Jones RN
    Diagn Microbiol Infect Dis; 1998 Apr; 30(4):251-5. PubMed ID: 9582584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentration-dependent synergy and antagonism within a triple antifungal drug combination against Aspergillus species: analysis by a new response surface model.
    Meletiadis J; Stergiopoulou T; O'Shaughnessy EM; Peter J; Walsh TJ
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2053-64. PubMed ID: 17387150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.
    Lalitha P; Shapiro BL; Srinivasan M; Prajna NV; Acharya NR; Fothergill AW; Ruiz J; Chidambaram JD; Maxey KJ; Hong KC; McLeod SD; Lietman TM
    Arch Ophthalmol; 2007 Jun; 125(6):789-93. PubMed ID: 17562990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do antibacterial and antifungal combinations have better activity against clinically relevant fusarium species? in vitro synergism.
    Venturini TP; Al-Hatmi AMS; Rossato L; Azevedo MI; Keller JT; Weiblen C; Santurio JM; Alves SH
    Int J Antimicrob Agents; 2018 May; 51(5):784-788. PubMed ID: 29127050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro synergy of caspofungin with licensed and novel antifungal drugs against clinical isolates of Fusarium spp.
    Shalit I; Shadkchan Y; Mircus G; Osherov N
    Med Mycol; 2009; 47(5):457-62. PubMed ID: 18720217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro synergistic interaction between amphotericin B and micafungin against Scedosporium spp.
    Yustes C; Guarro J
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3498-500. PubMed ID: 16048969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus.
    Cuenca-Estrella M; Gomez-Lopez A; Garcia-Effron G; Alcazar-Fuoli L; Mellado E; Buitrago MJ; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1232-5. PubMed ID: 15728937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate (MK-0991).
    Espinel-Ingroff A
    J Clin Microbiol; 2003 Jan; 41(1):403-9. PubMed ID: 12517880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi.
    Diekema DJ; Messer SA; Hollis RJ; Jones RN; Pfaller MA
    J Clin Microbiol; 2003 Aug; 41(8):3623-6. PubMed ID: 12904365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.